1-10 of 10
Per-Ola Andersson, MD PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Outcome By Primary Treatment Type and Timing of Progression Among Follicular Lymphoma Patients: A Large, Population-Based Study in Sweden

Caroline Weibull, Björn E Wahlin, MD PhD, Sandra Lockmer, Gunilla Enblad, Per-Ola Andersson, MD PhD, Eva Kimby, MD PhD, Karin E. Smedby, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 46–47.
https://doi.org/10.1182/blood-2020-140228
Published: 2020
Journal Articles

Evaluation of Eligibility for CAR-T Cell Therapy in a Population-Based Cohort of 3550 Patients with Incident Diffuse Large B-Cell Lymphoma (DLBCL) in Sweden

Karin Ekstroem Smedby, Sara Harrysson, MD, Sara Ekberg, Mats Jerkeman, MD PhD, Per-Ola Andersson, MD PhD, Gunilla Enblad, Sandra Eloranta
Journal: Blood
Blood (2020) 136 (Supplement 1): 38–39.
https://doi.org/10.1182/blood-2020-138737
Published: 2020
Journal Articles

Incidence of Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Including CNS Relapse in a Population-Based Cohort of 4205 Patients in Sweden

Sara Harrysson, MD, Sandra Eloranta, Sara Ekberg, Gunilla Enblad, Mats Jerkeman, MD Professor, Sverker Hasselblom, Björn E Wahlin, MD PhD, Per-Ola Andersson, MD PhD, Karin E. Smedby, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 399.
https://doi.org/10.1182/blood-2019-122014
Published: 2019
Journal Articles

Treatment Intensity, Timing of Relapse and Outcome of 713 Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) in a Population-Based Setting in Sweden

Karin Ekstrom Ekstroem Smedby, Sara Ekberg, Sandra Eloranta, Gunilla Enblad, Mats Jerkeman, MD Professor, Per-Ola Andersson, MD PhD, Sara Harrysson, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4111.
https://doi.org/10.1182/blood-2019-123785
Published: 2019
Journal Articles

Quantitative Proteomics in Diffuse Large B-Cell Lymphoma Patients Reveal Novel Overexpressed Proteins and Potentially Druggable Targets in the ABC Subtype

Susanne Bram Ednersson, MD, Mimmie Stern, MD, Henrik Fagman, Gunilla Enblad, Ulf-Henrik Mellqvist, MD PhD, Herman Nilsson-Ehle, MD PhD, Sverker Hasselblom, Per-Ola Andersson, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3967.
https://doi.org/10.1182/blood-2019-126387
Published: 2019
Journal Articles

Serum Metabolomic Profiling Correlated with ISS and Clinical Outcome for Multiple Myeloma Patients Treated with High Dose Melphalan and Autologous Stem Cell Transplantation

Ljupco Veskovski, MD, Per-Ola Andersson, MD PhD, Ingemar Turesson, MD PhD, Daniel Malmodin, PhD, Anders Pedersen, PhD, Ulf-Henrik Mellqvist, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1771.
https://doi.org/10.1182/blood-2019-121961
Published: 2019
Journal Articles

Real-World Results on Ibrutinib in Relapsed/Refractory CLL: A 21-Month Follow-up of 95 Swedish Patients Treated in a Compassionate Use Program

Maria Winqvist, MSc, MD, Per-Ola Andersson, MD PhD, Anna Asklid, MD, Karin Karlsson, MD, Claes Karlsson, MD PhD, Birgitta Lauri, MD, Jeanette Lundin, MD PhD Assoc Prof, Mattias Mattsson, MD, Stefan Norin, MD PhD, Anna Bergendahl Sandstedt, MD, Lotta Hansson, Anders Österborg, MD PhD Prof.
Journal: Blood
Blood (2017) 130 (Supplement 1): 5353.
https://doi.org/10.1182/blood.V130.Suppl_1.5353.5353
Published: 2017
Journal Articles

Incidence and Outcome in Aplastic Anemia Diagnosed 2000-2011 - a Nationwide Swedish Registry Study

Krista Vaht, MD, Magnus Göransson, MD PhD, Kristina Carlson, MD PhD, Cecilia Isaksson, MD, Stig Lenhoff, Anna Sandstedt, MD, Bertil Uggla, MD PhD, Per T. Ljungman, MD PhD, Mats Brune, MD PhD, Per-Ola Andersson, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3905.
https://doi.org/10.1182/blood.V128.22.3905.3905
Published: 2016
Journal Articles

Overexpression of Ribosomal Proteins Is Associated with Resistance to Immunochemotherapy in Diffuse Large B-Cell Lymphoma Patients

Martin Stenson, MD, Susanne Bram-Ednersson, MD, Herman Nilsson-Ehle, MD PhD, Mimmie Stern, MD, Gunilla Enblad, Sverker Hasselblom, MD PhD, Per-Ola Andersson, MD PhD
Journal: Blood
Blood (2016) 128 (22): 4121.
https://doi.org/10.1182/blood.V128.22.4121.4121
Published: 2016
Journal Articles

Reactive Oxygen Species Produced By Myeloid Cells Block CD20-Antibody Dependent NK Cell-Mediated Cytotoxicity Against Chronic Lymphocytic Leukemia Cells

Olle Werlenius, MD, Johan Aurelius, PhD, Maria Simpanen, Rebecca E Riise, Ali A Akhiani, PhD, Anna Martner, PhD, Per-Ola Andersson, MD PhD, Kristoffer Hellstrand, MD, Fredrik B Thorén, PhD
Journal: Blood
Blood (2014) 124 (21): 3638.
https://doi.org/10.1182/blood.V124.21.3638.3638
Published: 2014